| 價(jià)格 | 詢價(jià) |
| 包裝 | 1支 |
| 最小起訂量 | 1支 |
| 發(fā)貨地 | 湖北 |
| 更新日期 | 2026-07-08 |
| 中文名稱:重組小鼠APRIL (N-Fc)蛋白 | 英文名稱:Recombinant Mouse APRIL (N-Fc) |
| 品牌: EnkiLife | 產(chǎn)地: 中國(guó) |
| 保存條件: Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. | 產(chǎn)品類別: 重組蛋白 |
| 是否進(jìn)口: 否 | 用途: 科研 |
| 產(chǎn)品名稱 |
Recombinant Mouse APRIL (N-Fc) |
| 英文名稱 |
APRIL/TNFSF13/CD256/TALL2 |
| 純度 |
Greater than 95% as determined by reducing SDS-PAGE |
| 內(nèi)毒素 |
<1 EU/μg as determined by LAL test. |
| 蛋白構(gòu)建 |
Recombinant Mouse Tumor Necrosis Factor Ligand Superfamily Member 13 is produced by our Mammalian expression system and the target gene encoding Ala96-Leu240 is expressed with a human IgG1 Fc tag at the N-terminus. |
| Accession |
AAG22534.1 |
| 表達(dá)宿主 |
Human Cells |
| 種屬 |
Mouse |
| 預(yù)測(cè)分子量 |
42.7 KDa |
| 制劑 |
Lyophilized from a 0.2 μm filtered solution of 20mM PB, 8% Sucrose, 0.05% Tween 80, pH 6.0. |
| 運(yùn)輸方式 |
The product is shipped at ambient temperature.Upon receipt, store it immediately at the temperature listed below. |
| 穩(wěn)定性&儲(chǔ)存 |
Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. |
| 復(fù)溶 |
Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
| 分子別名 |
| A proliferation-inducing ligand; TNFSF13; TALL-2; TRDL-1; CD256 |
| 背景介紹 |
| Tumor necrosis factor ligand superfamily member 13 belongs to the tumor necrosis factor family. It is also known as APRIL, TALL2, TRDL1, and CD256. It is synthesized as a 32 kDa proprotein which is cleaved by furin in the Golgi to release the active 17 kDa soluble molecule. TNFSF13 is a Cytokine that binds to TNFRSF13B/TACI and to TNFRSF17/BCMA and plays a role in the regulation of tumor cell growth. It expressed at high levels in transformed cell lines, cancers of colon, thyroid, lymphoid tissues and specifically expressed in monocytes and macrophages. Its expression by CD4+ T cells inhibits the production of Th2 cytokines and allergic inflammation. |
注意事項(xiàng)
本司產(chǎn)品僅用于科研,不用于臨床診斷和治療
| 成立日期 | 2024-08-02 (2年) | 注冊(cè)資本 | 271萬(wàn)人民幣 |
| 員工人數(shù) | 10-50人 | 年?duì)I業(yè)額 | ¥ 100萬(wàn)-300萬(wàn) |
| 主營(yíng)行業(yè) | 生化試劑,抗體,細(xì)胞培養(yǎng),癌癥研究,細(xì)胞生物學(xué) | 經(jīng)營(yíng)模式 | 工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| 詢價(jià) |
VIP3年
|
北京百普賽斯生物科技股份有限公司
|
2026-06-30 | |
| 詢價(jià) |
VIP4年
|
維百奧(北京)生物科技有限公司
|
2026-05-28 | |
| 詢價(jià) |
VIP5年
|
武漢艾美捷科技有限公司
|
2026-07-27 |